United Kingdom · 
Who invested in Enhanc3D Genomics?
Enhanc3D Genomics's investors include Business Growth Fund and Parkwalk.
United Kingdom · Series A startup
Who invested in Enhanc3D Genomics
Funding summaryUpdated 26 Oct 2026
$5.4Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $5.4MSept 2025
- Investors
- 2
The rounds
- Sept 2025
Founders and team
From Enhanc3D Genomics's own website: 1 founder, 4 on the team.
Prof. Peter FraserCo-Founder
- Dr. Dan TurnerChief Technology Officer
- Catherine MauriceFinance Director
- Dr. Anne DobréeBoard Director
- Lucy Edwardes-JonesBoard Director
AdvisersDr. Stefan Schoenfelder
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Enhanc3D Genomics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Enhanc3D Genomics
How much has Enhanc3D Genomics raised?
Enhanc3D Genomics has raised $5.4M across 1 round since 2025.
When did Enhanc3D Genomics last raise?
Enhanc3D Genomics's most recent round was a Series A of $5.4M in Sept 2025.
What was Enhanc3D Genomics's biggest round?
Its most recent round, $5.4M in Sept 2025, is also its largest on record.
Who backed Enhanc3D Genomics first?
Enhanc3D Genomics's first round on record, in Sept 2025, was backed by Business Growth Fund and Parkwalk.
What stage is Enhanc3D Genomics at?
Enhanc3D Genomics's latest named round is a Series A, in Sept 2025.
Where is Enhanc3D Genomics based?
Enhanc3D Genomics is based in the United Kingdom.
Companies like Enhanc3D Genomics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.